{{Drugbox
| verifiedrevid = 
| IUPAC_name = 3-Methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one
| image = Mexedrone.svg

<!--Clinical data-->
| tradename = 
| legal_CA = Schedule I
| legal_UK = PSA
| legal_status = Illegal in Japan and Sweden

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| DrugBank_Ref = 
| PubChem = 
| ChemSpiderID = 

<!--Chemical data-->
| C=12 | H=17 | N=1 | O=2
| smiles = COCC(C(=O)C1=CC=C(C=C1)C)NC
| StdInChI = 1S/C12H17NO2/c1-9-4-6-10(7-5-9)12(14)11(13-2)8-15-3/h4-7,11,13H,8H2,1-3H3
| StdInChIKey = JHGDCSPZKQLBOP-UHFFFAOYSA-N
}}

'''Mexedrone''' is a [[stimulant]] [[drug]] of the [[substituted cathinone|cathinone]] [[chemical class|class]] that has been sold online as a [[designer drug]].<ref>{{cite web|url=http://nsddb.eu/substance/528/|title=Mexedrone|work=New Synthetic Drug Database}}</ref><ref>{{cite journal|first1=Zhenhua|last1=Qian|first2=Wei|last2=Jia|first3=Tao|last3=Li|first4=Cuimei|last4=Liu|title=Identification and analytical characterization of four synthetic cathinone derivatives iso-4-BMC, β-TH-naphyrone, mexedrone, and 4-MDMC|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.1983/abstract|journal=Drug Testing and Analysis|date=2016|issn=1942-7611|volume=|issue=|pages=|doi=10.1002/dta.1983|pmid=27352812|first5=Zhendong|last5=Hua}}</ref> It is the alpha-methoxy [[Derivative (chemistry)|derivative]] of [[Mephedrone]].

== Pharmacology ==

Mexedrone acts as a weak [[serotonin–norepinephrine–dopamine reuptake inhibitor]] (SNDRI) with [[IC50|IC<sub>50</sub>]] values of 5289 nM, 8869 nM and 6844 nM, respectively, as well as a weak [[serotonin releasing agent]] (SRA) with an [[EC50|EC<sub>50</sub>]] value of 2525 nM.<ref>{{cite journal|first1=Gavin|last1=McLaughlin|first2=Noreen|last2=Morris|first3=Pierce V.|last3=Kavanagh|first4=John D.|last4=Power|title=Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone|url=http://onlinelibrary.wiley.com/doi/10.1002/dta.2053/abstract|journal=Drug Testing and Analysis|date=2016|issn=1942-7611|volume=|issue=|pages=|doi=10.1002/dta.2053|pmid=27524685|first5=Geraldine|last5=Dowling|first6=Brendan|last6=Twamley|first7=John|last7=O'Brien|first8=Brian|last8=Talbot|first9=Donna|last9=Walther|first10=John S.|last10=Partilla|first11=Michael H.|last11=Baumann|first12=Simon D.|last12=Brandt}}</ref>

== Legal status ==
Mexedrone is illegal in Sweden as of 26. January 2016<ref>{{cite web | url=https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/november/31-nya-amnen-kan-klassas-som-narkotika-eller-halsofarlig-vara/ | title=31 nya ämnen kan klassas som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | language=sv| date=November 2015}}</ref> as well as Japan as of 24. August 2016.<ref>{{cite web | url=http://www.mhlw.go.jp/seisakunitsuite/bunya/kenkou_iryou/iyakuhin/yakubuturanyou/dl/meisho.pdf | title=指定薬物一覧 | publisher=Ministry of Health, Labour and Welfare | language=Japanese}}</ref>

== See also ==
* [[4-Methylcathinone]]
* [[4-Methylbuphedrone]]
* [[4-Methylethcathinone]]
* [[Zylofuramine]]

== References ==
{{reflist}}

{{Stimulants}}
{{Phenethylamines}}

[[Category:Cathinones]]
[[Category:Designer drugs]]
[[Category:Serotonin-norepinephrine-dopamine reuptake inhibitors]]
[[Category:Serotonin releasing agents]]


{{pharma-stub}}